Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited
Cardiovascular Ultrasound

Predictors of recurrence in patients with paroxysmal atrial fibrillation after circumferential pulmonary vein radiofrequency ablation

  • Min Xu ,
  • Fei Liu ,
  • Zhixiang Ge ,
  • Yuxia Miao ,
  • Jun Meng ,
  • Zhenni. Yang
Expand
  • 1. Echocardiogram Room of Changzhou First People's Hospital, the Third Affiliated Hospital of Suzhou University, Changzhou 213003, China
Corresponding author: Yang Zhenni, Email:

Received date: 2020-02-14

  Online published: 2020-12-01

Abstract

Objective

To observe the significance of left atrial (LA) function combined with B-type natriuretic peptide (BNP) in predicting the recurrence of paroxysmal atrial fibrillation (PAF) after cardiopulmonary vein ablation (CPVA).

Methods

A total of 201 PAF patients from Changzhou NO.1 People's Hospital who planned to receive the first CPVA operation were selected. According to the results of dynamic electrocardiogram 3 months after CPVA, AF patients were divided into either a sinus rhythm group or a recurrence group. Multivariate logistic regression analysis was performed to analyze the independent factors influencing the recurrence of PAF after CPVA. Receiver operating characteristic (ROC) curve analysis was used to compare the diagnostic efficiency of each index.

Results

Of the 201 AF patients who underwent CPVA, 36 (17.9%) experienced recurrent AF during follow-up. BNP in the recurrence group was significantly higher than that of the sinus rhythm group (P<0.05). There were significant differences in LA minimum volume index (LAVImin), LA maximum volume index (LAVImax), expansion index (EI), diastolic ejection index (DEI), passive ejection index (PEI), and active ejection index (AEI) between the two groups P<0.05 for all). Multivariate logistic regression analysis showed that BNP, DEI, and history of PAF were independent predictors of AF recurrence (P<0.05). ROC curve analysis showed that the areas under the ROC curves (AUCs) of DEI and combination index (DEI+BNP) were both better than LAVImin (AUC: 0.881 vs 0.686, 0.901 vs 0.686, P<0.05 for both), and the specificity of the combination index (DEI+BNP) was better than either of them alone (89.7% vs 79.4%, 89.7% vs 72.7%, P<0.05 for both).

Conclusions

In patients with PAF treated by CPVA, impaired LA storage function and increased BNP are independent predictors of AF recurrence after CPVA. The combination of the two can improve the specificity of diagnosis.

Cite this article

Min Xu , Fei Liu , Zhixiang Ge , Yuxia Miao , Jun Meng , Zhenni. Yang . Predictors of recurrence in patients with paroxysmal atrial fibrillation after circumferential pulmonary vein radiofrequency ablation[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2020 , 17(12) : 1220 -1226 . DOI: 10.3877/cma.j.issn.1672-6448.2020.12.014

References

1
Morillo CA, Verma A, Connolly SJ, et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial [J]. JAMA, 2014, 311(7):692-700.
2
Calkins H, Kuck KH, Cappato R, et al. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design [J]. J Interv Card Electrophysiol, 2012, 33(2):171-257.
3
Iwasaki YK, Nishida K, Kato T, et al. Atrial fibrillation pathophysiology: implications for management [J]. Circulation, 2011, 124(20): 2264-2274.
4
Mor-Avi V, Yodwut C, Jenkins C, et al. Real-time 3D echocardiographic quantification of left atrial volume: multicenter study for validation with CMR[J]. JACC Cardiovasc Imaging, 2012, 5(8): 769-777.
5
Zhang Y, Chen A, Song L, et al. Association between baseline natriuretic peptides and atrial fibrillation recurrence after catheter ablation [J]. Int Heart J, 2016, 57(2): 183-189.
6
Thomas L, Marwick TH, Popescu BA, et al. Left atrial structure and function, and left ventricular diastolic dysfunction: JACC state-of-the-art review [J]. J Am Coll Cardiol, 2019, 73(15): 1961-1977.
7
Miyasaka Y, Tsujimoto S, Maeba H, et al. Left atrial volume by real-time three-dimensional echocardiography: validation by 64-slice multidetector computed tomography [J]. J Am Soc Echocardiogr, 2011, 24(6): 680-686.
8
Geelhoed B, B?rschel CS, Niiranen T, et al. Assessment of causality of natriuretic peptides and atrial fibrillation and heart failure: a Mendelian randomization study in the FINRISK cohort [J]. Europace, 2020, 22(10): 1463-1469.
9
Allessie M, Ausma J, Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation [J]. Cardiovasc Res, 2002, 54(2):230-246.
10
Pathak R, Lau DH, Mahajan R, et al. Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation[J]. J Atr Fibrillation, 2013, 6(4): 986.
11
Fornengo C, Antolini M, Frea S, et al. Prediction of atrial fibrillation recurrence after cardioversion in patients with left-atrial dilation[J]. Eur Heart J Cardiovasc Imaging, 2015, 16(3): 335-341.
12
Olsen FJ, Bertelsen L, de Knegt MC, et al. Multimodality cardiac imaging for the assessment of left atrial function and the association with atrial arrhythmias[J]. Circ Cardiovasc Imaging, 2016, 9(10): e004947.
13
Nagaya M, Kawasaki M, Tanaka R, et al. Quantitative validation of left atrial structure and function by two-dimensional and three-dimensional speckle tracking echocardiography: a comparative study with three-dimensional computed tomography [J]. J Cardiol, 2013, 62(3): 188-194.
14
Habibi M, Lima J, Gucuk Ipek E, et al. The association of baseline left atrial structure and function measured with cardiac magnetic resonance and pulmonary vein isolation outcome in patients with drug-refractory atrial fibrillation[J]. Heart Rhythm, 2016, 13(5): 1037-1044.
15
Degiovanni A, Boggio E, Prenna E, et al. Association between left atrial phasic conduit function and early atrial fibrillation recurrence in patients undergoing electrical cardioversion[J]. Clin Res Cardiol, 2018, 107(4): 329-337.
16
Gould PA, Gula LJ, Bhayana V, et al. Characterization of cardiac brain natriuretic peptide release in patients with paroxysmal atrial fibrillation undergoing left atrial ablation[J]. Circ Arrhythm Electrophysiol, 2010, 3(1): 18-23.
17
Bernard-Brunet A, Saint Etienne C, Piver E, et al. Incomplete recovery of mechanical and endocrine left atrial functions one month after electrical cardioversion for persistent atrial fibrillation: a pilot study [J]. J Transl Med, 2014, 12: 51.
18
Xu X, Tang Y. Relationship between brain natriuretic peptide and recurrence of atrial fibrillation after successful electrical cardioversion: an updated meta-analysis [J]. Braz J Cardiovasc Surg, 2017, 32(6): 530-535.
19
Silvet H, Young-Xu Y, Walleigh D, et al. Brain natriuretic peptide is elevated in outpatients with atrial fibrillation [J]. Am J Cardiol, 2003, 92(9): 1124-1127.
20
Jiang H, Wang W, Wang C, et al. Association of pre-ablation level of potential blood markers with atrial fibrillation recurrence after catheter ablation: a meta-analysis [J]. Europace, 2017, 19(3): 392-400.
21
Springer J, Azer J, Hua R, et al. The natriuretic peptides BNP and CNP increase heart rate and electrical conduction by stimulating ionic currents in the sinoatrial node and atrial myocardium following activation of guanylyl cyclase-linked natriuretic peptide receptors [J]. J Mol Cell Cardiol, 2012, 52(5): 1122-1134.
22
Sramko M, Wichterle D, Melenovsky V, et al. Independent effect of atrial fibrillation on natriuretic peptide release [J]. Clin Res Cardiol, 2019, 108(2): 142-149.
Outlines

/

Copyright © Chinese Journal of Medical Ultrasound (Electronic Edition), All Rights Reserved.
Tel: 010-51322630、2632、2628 Fax: 010-51322630 E-mail: csbjb@cma.org.cn
Powered by Beijing Magtech Co. Ltd